Cantitate/Preț
Produs

Strategies to Enhance the Therapeutic Ratio of Radiation as a Cancer Treatment

Editat de Mitchell S. Anscher, Kristoffer Valerie
en Limba Engleză Hardback – 2 noi 2016

This volume will describe recent progress and future directions in radiation oncology and biology research, focusing on strategies designed to improve disease control and reduce the risk of long-term adverse effects on patients. As more and more patients are becoming long-term survivors, this strategy will become increasingly important--in radiation oncology and throughout the field of oncology.
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 107297 lei  6-8 săpt.
  Springer International Publishing – 4 iul 2018 107297 lei  6-8 săpt.
Hardback (1) 107977 lei  6-8 săpt.
  Springer International Publishing – 2 noi 2016 107977 lei  6-8 săpt.

Preț: 107977 lei

Preț vechi: 113659 lei
-5% Nou

Puncte Express: 1620

Preț estimativ în valută:
20662 21737$ 17151£

Carte tipărită la comandă

Livrare economică 16-30 ianuarie 25

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9783319455921
ISBN-10: 3319455923
Pagini: 394
Ilustrații: VI, 305 p. 65 illus., 53 illus. in color.
Dimensiuni: 155 x 235 x 19 mm
Greutate: 0.61 kg
Ediția:1st ed. 2016
Editura: Springer International Publishing
Colecția Springer
Locul publicării:Cham, Switzerland

Cuprins

1. Mechanisms of Normal Tissue Response.- 2. The Role of Hypoxia in Radiation Response.- 3. The Role of Cancer Stem Cells in Tumour Radioresponse.- 4. Novel Strategies to Prevent, Mitigate or Reverse Radiation Injury and Fibrosis.- 5. Technology Based Strategies to Enhance the Therapeutic Ratio.- 6. Nitric Oxide Synthase Uncoupling in Tumor Progression and Cancer Therapy.- 7. Aiming the Immune System to Improve the Antitumor Efficacy of Radiation Therapy.- 8. The Role of MicroRNAs in modulating Tissue Response to Radiation.- 9. Adapting Therapy Based on Tumor Response.- 10. NQO1 Bioactivatable Drugs Modify Radiation Responses.- 11. DNA Repair Pathways as a Potential Target for Radiosensitization.- 12. Radiosensitizing Glioma by Targeting ATM with Small Molecule Inhibitors.

Notă biografică

Mitchell S. Anscher, MD, FACR, FACRO, FASTRO, is Professor, Department of Radiation Oncology, Virginia Commonwealth University School of Medicine.
Kristoffer Valerie, PhD, is Professor, Division of Molecular Radiobiology, Department of Radiation Oncology, Co-Leader, Radiation Biology & Oncology Program, Massey Cancer Center, Virginia Commonwealth University. 

Textul de pe ultima copertă


This volume will describe recent progress and future directions in radiation oncology and biology research, focusing on strategies designed to improve disease control and reduce the risk of long-term adverse effects on patients. As more and more patients are becoming long-term survivors, this strategy will become increasingly important--in radiation oncology and throughout the field of oncology.

Caracteristici

Describes the recent progress and future directions in radiation oncology and biology research
Focuses on strategies designed to improve disease control and reduce the risk of long-term adverse effects on patients
Enables practitioners to understand an increasingly important strategy in radiation oncology and throughout the field of oncology